603363.SH
傲农生物
SSE · Consumer Defensive · Agricultural Farm Products · CN
CNY 2.84
−1.73%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 8.9B | 8.5B | 8.8B | 19.5B | 21.6B |
| Cost of Revenue | 8.4B | 7.9B | 8.4B | 20.4B | 20.7B |
| Gross Profit | 475.0M | 532.8M | 395.9M | (922.1M) | 948.2M |
| Operating Expenses | |||||
| R&D Expense | 54.6M | 49.8M | 54.5M | 148.9M | 161.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 324.4M | 327.3M | 870.1M | 713.6M | 663.6M |
| Selling & Marketing Expense | 213.1M | 209.7M | 263.6M | 360.2M | 412.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 745.9M | 753.0M | 1.9B | 1.8B | 1.8B |
| Cost and Expenses | 9.2B | 8.7B | 10.2B | 22.2B | 22.5B |
| Operating Income (EBIT) | (168.1M) | 97.8M | 417.4M | (3.7B) | (1.3B) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (158.0M) | 105.3M | 84.5M | (3.7B) | (1.3B) |
| Income Tax Expense | 17.0M | 15.9M | 21.4M | 87.1M | (69.2M) |
| Bottom Line | |||||
| Net Income | (154.0M) | 77.6M | 579.3M | (3.7B) | (1.0B) |
| Earnings from Cont. Ops | (175.1M) | 89.4M | 63.1M | (3.8B) | (1.2B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (154.0M) | 77.6M | 579.3M | (3.7B) | (1.0B) |
| Per Share | |||||
| Basic EPS | (CN¥0.06) | CN¥0.03 | CN¥0.67 | (CN¥4.21) | (CN¥1.34) |
| Diluted EPS | (CN¥0.06) | CN¥0.03 | CN¥0.67 | (CN¥4.21) | (CN¥1.34) |
| Revenue Per Share | CN¥6.67 | CN¥3.28 | — | CN¥22.44 | CN¥27.89 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 2.6B | — | 867.2M | 774.9M |
| Diluted Shares Outstanding | 1.3B | 2.6B | — | 867.2M | 774.9M |
| Profitability Metrics | |||||
| EBITDA | — | 533.9M | 1.1B | (2.7B) | (391.0M) |
| D&A | — | 436.1M | 697.6M | 910.5M | 920.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026